Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events
ConclusionsIn patients who receive clopidogrel after PCI, concomitant use of PPI seems to increase the risk of major cardiovascular events.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Angioplasty | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Clopidogrel | Congestive Heart Failure | Coronary Angioplasty | Coronary Heart Disease | Diabetes | Eating Disorders & Weight Management | Endocrinology | Heart | Heart Attack | Heart Disease | Heart Failure | Hypertension | Obesity | Percutaneous Coronary Intervention | Plavix | Proton Pump Inhibitors PPIs | Smokers | Stroke | Study | Sweden Health